ALL2008 Protocol for Childhood Acute Lymphoblastic Leukemia (ALL) - 6MP Consolidation Therapy

Mise à jour : Il y a 4 ans
Référence : NCT00816049

Femme et Homme

Extrait

The purpose of this study is to increase the fraction of patients, who become MRD-negative during consolidation for the non-HR ALL group through individualized intensification of the 6MP-dosage days 30-85.


Critère d'inclusion

  • Acute Lymphoblastic Leukemia


Liens